✦ LIBER ✦

6020 POSTER KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?

✍ Scribed by Selcukbiricik, F.; Yildiz, O.; Tural, D.; Ozturk, M.A.; Demir, G.; Ozguroglu, M.; Erdamar, S.; Buyukunal, E.; Mandel, N.M.; Serdengecti, S.

Book ID: 123526106
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 43 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(11)71665-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6060 KRAS and BRAF mutational analyses i

6060 KRAS and BRAF mutational analyses in a phase II trial of first-line FOLFOXIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts)

✍ Salvatore, L.; Loupakis, F.; Fontanini, G.; Cremolini, C.; Stasi, I.; Fabbri, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

6088 POSTER KRAS and EGFR MicroRNAs Regu

6088 POSTER KRAS and EGFR MicroRNAs Regulation and Cetuximab/Panitumumab Sensitivity in Metastatic Colorectal Cancer Patients

✍ Landi, L.; Biagioni, F.; Ludovini, V.; Sacconi, A.; D'Arcangelo, M.; Destro, A.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Quantitative Cell-Free DNA, KRAS, and BR

Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan

✍ Spindler, K.-L. G.; Pallisgaard, N.; Vogelius, I.; Jakobsen, A. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 311 KB

3617 POSTER Cost-Effectiveness of Cetuxi

3617 POSTER Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients With KRas Wild-Type Tumours in the United Kingdom

✍ Samyshkin, Y.; Hertel, N.; Griebsch, I. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Bevacizumab-containing Chemotherapy is S

Bevacizumab-containing Chemotherapy is Safe in Patients with Unresectable Metastatic Colorectal Cancer and a Synchronous Asymptomatic Primary Tumor

✍ Cetin, B.; Kaplan, M. A.; Berk, V.; Tufan, G.; Benekli, M.; Isikdogan, A.; Ozkan 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 150 KB

6136 POSTER Relatively High Discordant R

6136 POSTER Relatively High Discordant Rate of KRas Mutation Between Primary and Metastatic Sites, and a Different Pattern of KRas Mutational Status According to Metastatic Sites in Korean Patients With Colorectal Cancer

✍ Kim, M.J.; Lee, K.W.; Lee, H.S.; Kim, J.H.; Kim, Y.J.; Kwon, J.H.; Kim, D.W.; Ka 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB